NUCLEAR ONCOLOGY

Muhsin AUM. Cytologic diagnosis: a review. Bangladesh Med Res Counc Bull 2002; 28 (2): 82-86.

Chatal J-F. Recent advances in immunoscintigraphy and radioimmunotherapy. Kaku Igaku (Jpn J Nucl Med) 1997; 34:729- 30.

Hopkins CR, Reading CC: Thyroid and parathyroid imaging. Semin Ultrasound CT MRI 1995: 16: 279-295.

Price DC: Radioisotopic evaluation of the thyroid and parathyroids. Radiol Clin North Am 1993; 31: 991-1015.

Sherman SI Thyroid carcinoma Lancet 2003; 361:501-11.

Sherman SI, Tielens ET, Sostrs S, Wharam MD Jr, Ladenson PW Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma. J Clin Endocrinol Metab 1994; 78: 629-34.

Reynolds JC. Percent 131 I uptake and post-therapy 131 I scans: their role in the management of thyroid cancer. Thyroid 1997; 7: 281-84.

Fleming, J S Ackery, D.M. Walmsley, B H, Karran, S J Scintigraphic estimation of arterial and portal blood supplies to the liver. Journal ofNuclear Medicine, 1983; 24: 1108- 1113.

Leveson, S. H. Wiggins, P A Nasiru T A Giles GR, Robinson P J Improving the detection of hepatic metastases by the use of dynamic flow scintigraphy. British Journal of Cancer, 1983; 47: 719-721.

Borzutzky C A & Turbiner EH. The predictive value of hepatic artery perfusion scintigraphy. Journal of Nuclear Medicine. 1985: 26: 1153-1156.

Ziessman HA, Wahl RL, Juni JE, Gyves JE, Ensminger WD, Thrall JH, Keyes JWet al. The utility of SPECT for 99m Tc-MAA hepatic arterial perfusion scintigraphy. American Journal of Roentgenolgy, 1985; 145: 747-751.

Buscombe JR. Interventional nuclear medicine in hepatoellular carcinoma and other tumors Nucl Med Commun 2002; 23 (9): 837- 41.

Gnanase garan G, Buscombe J R. Neuroendocrine tumors-Part two. The role of nuclear medicine in treating Neuroendocrine tumors. World J Nucl Med 2003; 2: 314-323.

Roul J L, Guyander D, Bretagne J F, et al. Prospective randomized trial of chemoembolisation versus intra-arterial iodine-131 lipiodol in inoperable hepatocellular carcinoma. Hepatol 1997; 26: 1156-1161.

Anonymous. New drugs. Aust Prescr 2003; 26: 68.

Lechner P, Lind P, Goldenberg DM. Can postoperative surveillance with serial CEA immunoscintigraphy detect resectable rectal cancer recurrence and potentially improve tumor-free survival? J Am Coll Surg 2000; 191: 511-8.

Willkomm P, Bangard M, Decker P, Grunwald F, Biersack HJ. FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma. J Nucl Med 2000; 41: 1657-63.

Libutti SK, Alexander HR. Choyke P, Bartlett DL, Bacharach SL, Whatley M, et al. A prospective study of 2-fluoro-2-deoxy-D -glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels. Ann Surg Oncol 2001; 8: 779-86.

Goin JE, Dancey JE, Hermann GA, Sickles CJ, Roberts CA, Macdonald JS. Treatment of unresectable metastatic colorectal _ carcinoma to the liver with Intrahepatic Y-90 microspheres: dose-ranging study. World J Nucl Med 2003; 2 216-225.

Taher MA. Non-osseous uptake of Tc-99m phosphonate during three phase bone scan. ASEAN J Radiol 2003; IX: 83-84.

MckillopJ H. Bone Scanning In Metastatic Disease. In Fogelman I (editor): Bone Scanning in Clinical Practice London: Springer- Verlag, 1987.

Borak J. Relationship between the clinical and roentgenological findings in bone metastases. Surg Gynecol Obstet 1942; 75: 599-604.

Clain A. Secondary malignant disease of bone. Br J Cancer 1965; 19: 15-29

Shackman R, Harrison CV. Occult bone metastases. BrJ Surg 1947; 35:385-389.

Aoki J, Watanabe H, Shinozala T, Tokunaga M, Inoue T, Endo K. FDG-PET in differential diagnosis and grading of chondrosarcomas. J comput Assist Tomogr 1999 Jul-Aug; 23(4): 603-8.

Ho WY, Sentinel Node Imaging. Hong Kong College of Radiologists 10th Annual Scientific Meeting; 19th & 20th October 2002.

Ege GN. Internal mammary lympho scintigraphy the rationale, technique, Interpretation, and clinical application. Radiology1976; 118:101.

Abdel-Dayem HM, Siraj QH, Collier BD. Lymphoscintigraphy. In Maisey MN, Britton KE, Collier BD (eds): Clinical Nuclear Medicine, 3rd ed. pp. 541-552, Chapman & Hall, 1998, London.

Tauxe WN, Dubovsky EV. The genitourinary system. In Harbert J, Da Rocha AFG (editors): Textbook of Nuclear Medicine vol. II 1984, Philadelphia, Lea & Febiger, pp.481-521.

Beierwaltes WH, Sisson J C, Shapiro B. Radionuclide therapy of adrenocortical and medullary tumors. In Spencer R P, Seevers RH, Friedman A M (eds.): Radionuclides in therapy. 1987 C R C Press, Florida, pp. 47-62.

Wilson M A, Hammes R. J. Radiopharmaceuticals. In Wilson M A(ed): Textbook of Nuclear Medicine, 1998, LippincottRaven, Philadelphia, pp. 385-413.